Cite

HARVARD Citation

    Adotevi, O. et al. (2018). In situ delivery of allogeneic natural killer cell (NK) combined with Cetuximab in liver metastases of gastrointestinal carcinoma: A phase I clinical trial. Oncoimmunology. p. . [Online]. 
  
Back to record